Trials / Conditions / Common Warts (Verruca Vulgaris)
Common Warts (Verruca Vulgaris)
4 registered clinical trials studyying Common Warts (Verruca Vulgaris) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulga NCT07457918 | Verrica Pharmaceuticals Inc. | Phase 3 |
| Recruiting | Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir NCT07448844 | Riphah International University | Phase 4 |
| Recruiting | Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) NCT07246590 | Verrica Pharmaceuticals Inc. | Phase 3 |
| Completed | Candin for the Treatment of Common Warts NCT05889845 | Nielsen BioSciences, Inc. | Phase 3 |